Veteran's Interdisciplinary Care for Traumatic Brain Injury and Co-Occurring Disorders Rehabilitation Trial
VICTORY-RCT
1 other identifier
interventional
416
1 country
1
Brief Summary
The goal of this clinical trial is to learn if the Avalon Action Alliance Interdisciplinary Outpatient Rehabilitation Program (IORP) can reduce long-lasting symptoms of traumatic brain injury (TBI) and co-occurring disorders in veterans and first responders. The main questions it aims to answer are:
- Does a 3-week IORP reduce symptoms of long-lasting TBI and co-occurring disorders in military veterans and first responders?
- Does the 3-week IORP improve life quality and function in military veterans and first responders? Researchers will compare the Control group to the Invention group to see if a 3-week of IORP reduced symptoms of TBI and co-occurring disorders in military veterans and first responders. Participants will complete the following activities. The items with an asterisk(\*) are not required or available at all sites.
- Answer online survey questions about their TBI symptoms, life satisfaction, and life activities
- Complete two blood draws\*
- Complete two magnetic resonance imaging (MRI) brain scans\*
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2026
CompletedFirst Posted
Study publicly available on registry
March 10, 2026
CompletedStudy Start
First participant enrolled
March 26, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2029
April 2, 2026
March 1, 2026
2.9 years
February 27, 2026
March 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean change in Neurobehavioral Symptom Inventory (NSI)
The NSI is a 22-item self-report questionnaire used to assess neurobehavioral symptoms, particularly those following a TBI
Baseline enrollment to 3-month follow-up (post IORP)
Secondary Outcomes (3)
Mean change in Satisfaction with Life Scale (SWLS)
Baseline enrollment to 3 months post-IORP and 6 months post-IORP
Life Satisfaction Questionnaire (LISAT-11)
Baseline enrollment to 3 months post-IORP and 6 months post-IORP
Participation Assessment with Recombined Tools-Objective (PART-O)
Baseline enrollment to 3 months post-IORP and 6 months post-IORP
Study Arms (2)
Interdisciplinary Outpatient Rehabilitation Program Intervention Arm
OTHERParticipants in this arm will start the 3-Week TBI IORP after baseline evaluation and receiving the recommendation to participate in the IORP.
Control Waiting Period Arm
OTHERParticipants in this arm will start the 3-Week TBI IORP after observing at least a 3 month waiting period after baseline evaluation and receiving the recommendation to participate in the IORP.
Interventions
Interdisciplinary outpatient rehabilitation program (IORP) for military veterans and first responders experiencing chronic effects of traumatic brain injury (TBI) and co-occurring disorders (e.g., posttraumatic stress disorder, depression, substance use).
Eligibility Criteria
You may qualify if:
- Meets general eligibility requirements for site specific 3-week IORP
- Capable of providing informed consent for IORP and study participation
- English speaking
- to 65 years old
You may not qualify if:
- History of TBI of any severity in the past 6 months
- Active substance use disorder that precludes study participation
- Neurologic, psychiatric, or other medical condition that would prohibit full study participation
- Active-duty military service member
- Any other circumstance that, in the opinion of the investigator, would undermine the integrity or success of the project
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Diegocollaborator
- Moss Rehabilitation Research Institutecollaborator
- University of Colorado Denver - Anschutz Medical Campus (UCD-AMC)collaborator
- Medical College of Wisconsinlead
- University of North Carolina, Chapel Hillcollaborator
- University of Floridacollaborator
Study Sites (1)
BRAVE Program
Milwaukee, Wisconsin, 53226, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Neurosurgery
Study Record Dates
First Submitted
February 27, 2026
First Posted
March 10, 2026
Study Start
March 26, 2026
Primary Completion (Estimated)
February 1, 2029
Study Completion (Estimated)
May 1, 2029
Last Updated
April 2, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share